Get started
Author

E. Marielle Hijmans

Observed names: E M Hijmans, E Marielle Hijmans, E.M. HIJMANS, E.M. Hijmans
ORCID: 0000-0003-4847-9412
Observed ORCID: 0000-0003-4847-9412
OpenAlex ID: A5059618857
A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer
2007 · Katrien Berns, Hugo M. Horlings, et al. · Cancer Cell · 1,619
PDF
A large-scale RNAi screen in human cells identifies new components of the p53 pathway
2004 · Katrien Berns, E. Marielle Hijmans, et al. · Nature Cell Biology · 1,059
PDF
EGFR activation limits the response of liver cancer to lenvatinib
2021 · Haojie Jin, Yaoping Shi, et al. · Nature · 451
Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1
1998 · Renate M.L. Zwijsen, Robin S. Buckle, et al. · Genes & Development · 305
PDF
E2F-5, a New E2F Family Member That Interacts with p130 In Vivo
1995 · E. Marielle Hijmans, P. Mathijs Voorhoeve, et al. · Molecular and Cellular Biology · 226
Interaction of c‐Myc with the pRb‐related protein p107 results in inhibition of c‐Myc‐mediated transactivation.
1994 · R.L. Beijersbergen, E.M. Hijmans, et al. · The EMBO Journal · 139
Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity
1997 · Katrien Berns, E Marielle Hijmans, et al. · Oncogene · 114
E2F-7: a distinctive E2F family member with an unusual organization of DNA-binding domains
2004 · Nicola Logan, Laurent Delavaine, et al. · Oncogene · 111
PDF
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
2018 · Katrien Berns, Joseph J. Caumanns, et al. · Oncogene · 107
PDF
Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein
1999 · P Mathijs Voorhoeve, E Marielle Hijmans, et al. · Oncogene · 101
PR72, a novel regulator of Wnt signaling required for Naked cuticle function
2005 · Menno P. Creyghton, Giulietta Roël, et al. · Genes & Development · 74
PDF
mUBC9, a Novel Adenovirus E1A-interacting Protein That Complements a Yeast Cell Cycle Defect
1996 · Guus Hateboer, E. Marielle Hijmans, et al. · Journal of Biological Chemistry · 70
PDF
Loss of ARID1A Activates ANXA1 , which Serves as a Predictive Biomarker for Trastuzumab Resistance
2016 · Katrien Berns, Amir Sonnenblick, et al. · Clinical Cancer Research · 60
A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts
2000 · Katrien Berns, E Marielle Hijmans, et al. · Oncogene · 60
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
2018 · Joseph J. Caumanns, Katrien Berns, et al. · Clinical Cancer Research · 47
PDF
USP9X Downregulation Renders Breast Cancer Cells Resistant to Tamoxifen
2014 · Hendrika M. Oosterkamp, E. Marielle Hijmans, et al. · Cancer Research · 45
Molecular and functional characterisation of E2F-5, a new member of the E2F family.
1995 · V Buck, K E Allen, et al. · PubMed · 43
Functional Analysis of Burkitt's Lymphoma Mutant c-Myc Proteins
1996 · Birgitte Smith-S⊘rensen, E. Marielle Hijmans, et al. · Journal of Biological Chemistry · 42
PDF
A functionally distinct member of the DP family of E2F subunits
2006 · A Milton, K Luoto, et al. · Oncogene · 30
A Functional Genetic Screen Identifies TFE3 as a Gene That Confers Resistance to the Anti-proliferative Effects of the Retinoblastoma Protein and Transforming Growth Factor-β
2006 · Sebastian M.B. Nijman, E. Marielle Hijmans, et al. · Journal of Biological Chemistry · 25
PDF
Functional Identification of Cancer-relevant Genes through Large-Scale RNA Interference Screens in Mammalian Cells
2004 · T.R. BRUMMELKAMP, K. BERNS, et al. · Cold Spring Harbor Symposia on Quantitative Biology · 17
PDF
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
2022 · Marta Llaurado Fernandez, E. Marielle Hijmans, et al. · Molecular Cancer Therapeutics · 16
PDF
Abstract 3380: Synthetic lethal interaction between ARID1A mutation and BET bromodomain inhibition in ovarian clear cell carcinoma
2017 · Katrien Berns, Joseph J. Caumanns, et al. · Cancer Research · 2
Supplementary Data from NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
2023 · Marta Llaurado Fernandez, E. Marielle Hijmans, et al.
Supplementary Data from NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition
2023 · Marta Llaurado Fernandez, E. Marielle Hijmans, et al.
Works count: 89
Citation count: 4,763
H-index: 20
I10-index: 22
Year
Topic
Type